← Back to Search

Behavioral Intervention

TXTXT Intervention for HIV Adherence

N/A
Recruiting
Led By Amy Johnson, PhD
Research Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights

Study Summary

This trial will evaluate if TXTXT intervention can help improve adherence & viral load suppression in young people living with HIV.

Who is the study for?
This trial is for young people aged 16-35 with HIV who are on antiretroviral therapy (ART) but have a viral load of ≥200c/mL or haven't been taking their medication regularly. They must be able to get text messages and give informed consent, and they should already be patients at one of the participating clinics.Check my eligibility
What is being tested?
The study compares two groups in different clinics: one gets standard HIV care, while the other receives an additional text message-based intervention called TXTXT aimed at improving medication adherence. The effectiveness will be measured by how well participants stick to their ART regimen and their viral load after 3 and 6 months.See study design
What are the potential side effects?
Since this trial involves a non-medical intervention (text messaging), there are no direct medical side effects associated with it. However, participants may experience issues related to privacy if personal information is shared via texts.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HIV Medication Adherence
HIV-1 RNA Viral Load

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Clinics randomized to the intervention arm will have participants complete a 6-month intervention period. Clinics will sign up eligible participants to receive automated SMS messages from the Dimagi CommCare platform during the participant's baseline study visit. Participants will have the option to tailor the message content based on their own preferences and will be able to select to receive messages in English or in Spanish, the time the messages are delivered, and frequency of messages. Clinic staff will enter this information in the Dimagi CommCare platform, and then test receipt of text messages by the participant before they complete this baseline visit.
Group II: ComparisonActive Control1 Intervention
Clinics randomized to the comparison arm will have participants receive standard of care ART adherence support for 3 months, and will receive the TXTXT intervention for 3 months. The standard of care for ART adherence across clinic sites consists of routine follow-up from assigned case managers for appointment reminders and adherence counseling at scheduled visits .

Find a Location

Who is running the clinical trial?

Howard Brown Health CenterOTHER
10 Previous Clinical Trials
7,612 Total Patients Enrolled
KC Care Health CenterUNKNOWN
1 Previous Clinical Trials
200 Total Patients Enrolled
Ann & Robert H Lurie Children's Hospital of ChicagoLead Sponsor
260 Previous Clinical Trials
5,188,638 Total Patients Enrolled

Media Library

Standard of Care (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05783297 — N/A
Human Immunodeficiency Virus Infection Research Study Groups: Intervention, Comparison
Human Immunodeficiency Virus Infection Clinical Trial 2023: Standard of Care Highlights & Side Effects. Trial Name: NCT05783297 — N/A
Standard of Care (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05783297 — N/A
~80 spots leftby Aug 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top